{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:04:20Z","timestamp":1790291060560,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,2,4]],"date-time":"2016-02-04T00:00:00Z","timestamp":1454544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,2,4]],"date-time":"2016-02-04T00:00:00Z","timestamp":1454544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Behcet\u2019s disease (BD) is a chronic, systemic and recurrent inflammatory disease associated with hyperactive Th17 and Th1 immune responses. Recent studies have shown that B and T lymphocyte attenuator (BTLA) negatively regulates the immune response. In this study, we investigated whether BTLA activation could be exploited to inhibit the development of abnormal immune responses in BD patients. BTLA expression in PBMCs and CD4<jats:sup>+<\/jats:sup> T cells was significantly decreased in active BD patients. Decreased BTLA level was associated with increased Th17 and Th1 responses. Activation of BTLA inhibited the abnormal Th17 and Th1 responses and IL-22 expression in both patients and controls. Addition of an agonistic anti-BTLA antibody remarkably inhibited DC-induced Th17 and Th1 cell responses, resulted in decreased production of the Th17 and Th1-related cytokines IL-1beta, IL-6, IL-23 and IL-12p70 and reduced CD40 expression in DCs. In conclusion, decreased BTLA expression in ocular BD may lead to inappropriate control of the Th17 and Th1 immune responses and DC functions. Therefore, BTLA may be involved in the development and recurrence of this disease. Agonistic agents of BTLA may represent a potential therapeutic approach for the treatment of BD and other inflammatory diseases mediated by abnormal Th17 and Th1 immune responses.<\/jats:p>","DOI":"10.1038\/srep20401","type":"journal-article","created":{"date-parts":[[2016,2,4]],"date-time":"2016-02-04T10:28:00Z","timestamp":1454581680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Decreased B and T lymphocyte attenuator in Behcet\u2019s disease may trigger abnormal Th17 and Th1 immune responses"],"prefix":"10.1038","volume":"6","author":[{"given":"Zi","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaokui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dike","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aize","family":"Kijlstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peizeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,4]]},"reference":[{"key":"BFsrep20401_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/00004397-199030040-00010","volume":"30","author":"JB Michelson","year":"1990","unstructured":"Michelson, J. B. & Friedlaender, M. H. Behcet\u2019s disease. International ophthalmology clinics. 30, 271\u2013278 (1990).","journal-title":"International ophthalmology clinics."},{"key":"BFsrep20401_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/08820530500231953","volume":"20","author":"AA Bonfioli","year":"2005","unstructured":"Bonfioli, A. A. & Orefice, F. Behcet\u2019s disease. Seminars in ophthalmology. 20, 199\u2013206 (2005).","journal-title":"Seminars in ophthalmology"},{"key":"BFsrep20401_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0039-6257(05)80105-5","volume":"39","author":"RS Moorthy","year":"1995","unstructured":"Moorthy, R. S., Inomata, H. & Rao, N. A. Vogt-Koyanagi-Harada syndrome. Survey of ophthalmology. 39, 265\u2013292 (1995).","journal-title":"Survey of ophthalmology."},{"key":"BFsrep20401_CR4","first-page":"389","volume":"98","author":"S Murakami","year":"1994","unstructured":"Murakami, S., Inaba, Y., Mochizuki, M., Nakajima, A. & Urayama, A. [A nation-wide survey on the occurrence of Vogt-Koyanagi-Harada disease in Japan]. Nippon Ganka Gakkai zasshi. 98, 389\u2013392 (1994).","journal-title":"Nippon Ganka Gakkai zasshi."},{"key":"BFsrep20401_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/01.SMJ.0000100263.99708.10","volume":"97","author":"DG Federman","year":"2004","unstructured":"Federman, D. G., Kravetz, J. D., Ruser, C. B., Judson, P. H. & Kirsner, R. S. Vogt-Koyanagi-Harada syndrome and ulcerative colitis. Southern medical journal. 97, 169\u2013171 (2004).","journal-title":"Southern medical journal."},{"key":"BFsrep20401_CR6","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.autrev.2011.11.026","volume":"11","author":"M Pineton de Chambrun","year":"2012","unstructured":"Pineton de Chambrun, M., Wechsler, B., Geri, G., Cacoub, P. & Saadoun, D. New insights into the pathogenesis of Behcet\u2019s disease. Autoimmun Rev. 11, 687\u2013698 (2012).","journal-title":"Autoimmun Rev."},{"key":"BFsrep20401_CR7","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.jaci.2007.01.010","volume":"119","author":"W Chi","year":"2007","unstructured":"Chi, W. et al. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol. 119, 1218\u20131224 (2007).","journal-title":"J Allergy Clin Immunol."},{"key":"BFsrep20401_CR8","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1167\/iovs.07-1390","volume":"49","author":"W Chi","year":"2008","unstructured":"Chi, W. et al. Upregulated IL-23 and IL-17 in Behcet patients with active uveitis. Invest Ophthalmol Vis Sci. 49, 3058\u20133064 (2008).","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"BFsrep20401_CR9","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1038\/jid.2010.114","volume":"130","author":"NS Ekinci","year":"2010","unstructured":"Ekinci, N. S., Alpsoy, E., Karakas, A. A., Yilmaz, S. B. & Yegin, O. IL-17A has an important role in the acute attacks of Behcet\u2019s disease. J Invest Dermatol. 130, 2136\u20132138 (2010).","journal-title":"J Invest Dermatol."},{"key":"BFsrep20401_CR10","first-page":"S71","volume":"29","author":"K Hamzaoui","year":"2011","unstructured":"Hamzaoui, K. Th17 cells in Behcet\u2019s disease: a new immunoregulatory axis. Clinical and experimental rheumatology. 29, S71\u201376 (2011).","journal-title":"Clinical and experimental rheumatology."},{"key":"BFsrep20401_CR11","first-page":"S16","volume":"28","author":"J Kim","year":"2010","unstructured":"Kim, J. et al. Imbalance of Th17 to Th1 cells in Behcet\u2019s disease. Clinical and experimental rheumatology. 28, S16\u201319 (2010).","journal-title":"Clinical and experimental rheumatology."},{"key":"BFsrep20401_CR12","doi-asserted-by":"publisher","first-page":"4668","DOI":"10.1167\/iovs.12-9863","volume":"53","author":"C Wang","year":"2012","unstructured":"Wang, C. et al. Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci. 53, 4668\u20134675 (2012).","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"BFsrep20401_CR13","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1093\/rheumatology\/kem199","volume":"46","author":"S Guillaume-Czitrom","year":"2007","unstructured":"Guillaume-Czitrom, S. et al. Efficacy and safety of interferon-alpha in the treatment of corticodependent uveitis of paediatric Behcet\u2019s disease. Rheumatology. 46, 1570\u20131573 (2007).","journal-title":"Rheumatology."},{"key":"BFsrep20401_CR14","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/annrheumdis-2014-205571","volume":"74","author":"S Lightman","year":"2015","unstructured":"Lightman, S. et al. Pegylated interferon-alpha-2b reduces corticosteroid requirement in patients with Behcet\u2019s disease with upregulation of circulating regulatory T cells and reduction of Th17. Annals of the rheumatic diseases. 74, 1138\u20131144 (2015).","journal-title":"Annals of the rheumatic diseases."},{"key":"BFsrep20401_CR15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.clim.2008.12.007","volume":"131","author":"X Liu","year":"2009","unstructured":"Liu, X. et al. Inhibitory effect of Cyclosporin A and corticosteroids on the production of IFN-gamma and IL-17 by T cells in Vogt-Koyanagi-Harada syndrome. Clinical immunology. 131, 333\u2013342 (2009).","journal-title":"Clinical immunology."},{"key":"BFsrep20401_CR16","doi-asserted-by":"publisher","first-page":"e19870","DOI":"10.1371\/journal.pone.0019870","volume":"6","author":"M Sun","year":"2011","unstructured":"Sun, M. et al. Regulatory effects of IFN-beta on the development of experimental autoimmune uveoretinitis in B10RIII mice. PLoS One. 6, e19870 (2011).","journal-title":"PLoS One."},{"key":"BFsrep20401_CR17","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nri1917","volume":"6","author":"KM Murphy","year":"2006","unstructured":"Murphy, K. M., Nelson, C. A. & Sedy, J. R. Balancing co-stimulation and inhibition with BTLA and HVEM. Nat Rev Immunol. 6, 671\u2013681 (2006).","journal-title":"Nat Rev Immunol."},{"key":"BFsrep20401_CR18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1146\/annurev-immunol-030409-101202","volume":"28","author":"TL Murphy","year":"2010","unstructured":"Murphy, T. L. & Murphy, K. M. Slow down and survive: Enigmatic immunoregulation by BTLA and HVEM. Annu Rev Immunol. 28, 389\u2013411 (2010).","journal-title":"Annu Rev Immunol."},{"key":"BFsrep20401_CR19","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/ni944","volume":"4","author":"N Watanabe","year":"2003","unstructured":"Watanabe, N. et al. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol. 4, 670\u2013679 (2003).","journal-title":"Nat Immunol."},{"key":"BFsrep20401_CR20","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.bbrc.2003.11.070","volume":"312","author":"M Gavrieli","year":"2003","unstructured":"Gavrieli, M., Watanabe, N., Loftin, S. K., Murphy, T. L. & Murphy, K. M. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2. Biochem Biophys Res Commun. 312, 1236\u20131243 (2003).","journal-title":"Biochem Biophys Res Commun."},{"key":"BFsrep20401_CR21","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.4049\/jimmunol.181.5.2973","volume":"181","author":"C Deppong","year":"2008","unstructured":"Deppong, C., Degnan, J. M., Murphy, T. L., Murphy, K. M. & Green, J. M. B and T lymphocyte attenuator regulates T cell survival in the lung. J Immunol. 181, 2973\u20132979 (2008).","journal-title":"J Immunol."},{"key":"BFsrep20401_CR22","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.1073\/pnas.1222093110","volume":"110","author":"Y Kobayashi","year":"2013","unstructured":"Kobayashi, Y. et al. B and T lymphocyte attenuator inhibits LPS-induced endotoxic shock by suppressing Toll-like receptor 4 signaling in innate immune cells. Proc Natl Acad Sci USA. 110, 5121\u20135126 (2013).","journal-title":"Proc Natl Acad Sci USA."},{"key":"BFsrep20401_CR23","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1084\/jem.20071160","volume":"205","author":"MW Steinberg","year":"2008","unstructured":"Steinberg, M. W. et al. A crucial role for HVEM and BTLA in preventing intestinal inflammation. J Exp Med. 205, 1463\u20131476 (2008).","journal-title":"J Exp Med."},{"key":"BFsrep20401_CR24","doi-asserted-by":"publisher","first-page":"CR227","DOI":"10.12659\/MSM.881720","volume":"17","author":"K Hamzaoui","year":"2011","unstructured":"Hamzaoui, K. et al. Expression of Th-17 and RORgammat mRNA in Behcet\u2019s Disease. Medical science monitor: international medical journal of experimental and clinical research. 17, CR227\u2013234 (2011).","journal-title":"Medical science monitor: international medical journal of experimental and clinical research"},{"key":"BFsrep20401_CR25","doi-asserted-by":"publisher","first-page":"8098","DOI":"10.4049\/jimmunol.179.12.8098","volume":"179","author":"K Kreymborg","year":"2007","unstructured":"Kreymborg, K. et al. IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J Immunol. 179, 8098\u20138104 (2007).","journal-title":"J Immunol."},{"key":"BFsrep20401_CR26","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.20061308","volume":"203","author":"SC Liang","year":"2006","unstructured":"Liang, S. C. et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med. 203, 2271\u20132279 (2006).","journal-title":"J Exp Med."},{"key":"BFsrep20401_CR27","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1074-7613(04)00108-6","volume":"20","author":"J Banchereau","year":"2004","unstructured":"Banchereau, J., Pascual, V. & Palucka, A. K. Autoimmunity through cytokine-induced dendritic cell activation. Immunity. 20, 539\u2013550 (2004).","journal-title":"Immunity."},{"key":"BFsrep20401_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0952-7915(99)00059-X","volume":"12","author":"SD Reid","year":"2000","unstructured":"Reid, S. D., Penna, G. & Adorini, L. The control of T cell responses by dendritic cell subsets. Curr Opin Immunol. 12, 114\u2013121 (2000).","journal-title":"Curr Opin Immunol."},{"key":"BFsrep20401_CR29","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nri1349","volume":"4","author":"L Chen","year":"2004","unstructured":"Chen, L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol. 4, 336\u2013347 (2004).","journal-title":"Nat Rev Immunol."},{"key":"BFsrep20401_CR30","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1182\/blood-2007-08-109645","volume":"112","author":"BP Lawrence","year":"2008","unstructured":"Lawrence, B. P. et al. Activation of the aryl hydrocarbon receptor is essential for mediating the anti-inflammatory effects of a novel low-molecular-weight compound. Blood. 112, 1158\u20131165 (2008).","journal-title":"Blood."},{"key":"BFsrep20401_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000065883","volume":"129","author":"M Lechmann","year":"2002","unstructured":"Lechmann, M., Zinser, E., Golka, A. & Steinkasserer, A. Role of CD83 in the immunomodulation of dendritic cells. Int Arch Allergy Immunol. 129, 113\u2013118 (2002).","journal-title":"Int Arch Allergy Immunol."},{"key":"BFsrep20401_CR32","doi-asserted-by":"publisher","first-page":"8031","DOI":"10.1128\/JVI.00771-12","volume":"86","author":"S Boliar","year":"2012","unstructured":"Boliar, S. et al. B-lymphocyte dysfunction in chronic HIV-1 infection does not prevent cross-clade neutralization breadth. J Virol. 86, 8031\u20138040 (2012).","journal-title":"J Virol."},{"key":"BFsrep20401_CR33","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1007\/s00535-013-0762-9","volume":"48","author":"G Cai","year":"2013","unstructured":"Cai, G. et al. B and T lymphocyte attenuator is highly expressed on intrahepatic T cells during chronic HBV infection and regulates their function. J Gastroenterol. 48, 1362\u20131372 (2013).","journal-title":"J Gastroenterol."},{"key":"BFsrep20401_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1089\/vim.2009.0061","volume":"23","author":"XP Nan","year":"2010","unstructured":"Nan, X. P. et al. Circulating CD4+CD25 high regulatory T cells and expression of PD-1 and BTLA on CD4+ T cells in patients with chronic hepatitis B virus infection. Viral Immunol. 23, 63\u201370 (2010).","journal-title":"Viral Immunol."},{"key":"BFsrep20401_CR35","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1093\/infdis\/jir165","volume":"203","author":"Z Zhang","year":"2011","unstructured":"Zhang, Z. et al. B and T lymphocyte attenuator down-regulation by HIV-1 depends on type I interferon and contributes to T-cell hyperactivation. J Infect Dis. 203, 1668\u20131678 (2011).","journal-title":"J Infect Dis."},{"key":"BFsrep20401_CR36","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.4049\/jimmunol.0902487","volume":"185","author":"NE Serriari","year":"2010","unstructured":"Serriari, N. E. et al. B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function. J Immunol. 185, 3140\u20133148 (2010).","journal-title":"J Immunol."},{"key":"BFsrep20401_CR37","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.bbrc.2006.03.242","volume":"344","author":"N Otsuki","year":"2006","unstructured":"Otsuki, N., Kamimura, Y., Hashiguchi, M. & Azuma, M. Expression and function of the B and T lymphocyte attenuator (BTLA\/CD272) on human T cells. Biochem Biophys Res Commun. 344, 1121\u20131127 (2006).","journal-title":"Biochem Biophys Res Commun."},{"key":"BFsrep20401_CR38","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.immuni.2013.10.017","volume":"39","author":"V Bekiaris","year":"2013","unstructured":"Bekiaris, V., Sedy, J. R., Macauley, M. G., Rhode-Kurnow, A. & Ware, C. F. The inhibitory receptor BTLA controls gammadelta T cell homeostasis and inflammatory responses. Immunity. 39, 1082\u20131094 (2013).","journal-title":"Immunity."},{"key":"BFsrep20401_CR39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature14452","volume":"523","author":"N Gagliani","year":"2015","unstructured":"Gagliani, N. et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature. 523, 221\u2013225 (2015).","journal-title":"Nature."},{"key":"BFsrep20401_CR40","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jaci.2011.05.029","volume":"128","author":"G Geri","year":"2011","unstructured":"Geri, G. et al. Critical role of IL-21 in modulating TH17 and regulatory T cells in Behcet disease. J Allergy Clin Immunol. 128, 655\u2013664 (2011).","journal-title":"J Allergy Clin Immunol."},{"key":"BFsrep20401_CR41","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jneuroim.2011.01.012","volume":"233","author":"K Hamzaoui","year":"2011","unstructured":"Hamzaoui, K., Borhani Haghighi, A., Ghorbel, I. B. & Houman, H. RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Behcet\u2019s disease. J Neuroimmunol. 233, 249\u2013253 (2011).","journal-title":"J Neuroimmunol."},{"key":"BFsrep20401_CR42","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4049\/jimmunol.180.1.238","volume":"180","author":"C De Trez","year":"2008","unstructured":"De Trez, C. et al. The inhibitory HVEM-BTLA pathway counter regulates lymphotoxin receptor signaling to achieve homeostasis of dendritic cells. J Immunol. 180, 238\u2013248 (2008).","journal-title":"J Immunol."},{"key":"BFsrep20401_CR43","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1136\/ard.2009.126383","volume":"69","author":"RA Harry","year":"2010","unstructured":"Harry, R. A., Anderson, A. E., Isaacs, J. D. & Hilkens, C. M. Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis. Annals of the rheumatic diseases. 69, 2042\u20132050 (2010).","journal-title":"Annals of the rheumatic diseases."},{"key":"BFsrep20401_CR44","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.4049\/jimmunol.1102588","volume":"188","author":"MY Jung","year":"2012","unstructured":"Jung, M. Y., Kim, H. S., Hong, H. J., Youn, B. S. & Kim, T. S. Adiponectin induces dendritic cell activation via PLCgamma\/JNK\/NF-kappaB pathways, leading to Th1 and Th17 polarization. J Immunol. 188, 2592\u20132601 (2012).","journal-title":"J Immunol."},{"key":"BFsrep20401_CR45","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.4049\/jimmunol.1102481","volume":"188","author":"YM Tae","year":"2012","unstructured":"Tae, Y. M. et al. Airway activation of formyl peptide receptors inhibits Th1 and Th17 cell responses via inhibition of mediator release from immune and inflammatory cells and maturation of dendritic cells. J Immunol. 188, 1799\u20131808 (2012).","journal-title":"J Immunol."},{"key":"BFsrep20401_CR46","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/cei.12352","volume":"177","author":"C Wang","year":"2014","unstructured":"Wang, C., Ye, Z., Kijlstra, A., Zhou, Y. & Yang, P. Activation of the aryl hydrocarbon receptor affects activation and function of human monocyte-derived dendritic cells. Clin Exp Immunol. 177, 521\u2013530 (2014).","journal-title":"Clin Exp Immunol."},{"key":"BFsrep20401_CR47","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2174\/1566524014666140414210831","volume":"14","author":"Z Ye","year":"2014","unstructured":"Ye, Z., Wang, C., Kijlstra, A., Zhou, X. & Yang, P. A possible role for interleukin 37 in the pathogenesis of Behcet\u2019s disease. Curr Mol Med. 14, 535\u2013542 (2014).","journal-title":"Curr Mol Med."},{"key":"BFsrep20401_CR48","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","volume":"18","author":"J Banchereau","year":"2000","unstructured":"Banchereau, J. et al. Immunobiology of dendritic cells. Annu Rev Immunol. 18, 767\u2013811 (2000).","journal-title":"Annu Rev Immunol."},{"key":"BFsrep20401_CR49","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1126\/science.273.5283.1864","volume":"273","author":"IS Grewal","year":"1996","unstructured":"Grewal, I. S. et al. Requirement for CD40 ligand in costimulation induction, T cell activation and experimental allergic encephalomyelitis. Science. 273, 1864\u20131867 (1996).","journal-title":"Science."},{"key":"BFsrep20401_CR50","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1073\/pnas.0810769106","volume":"106","author":"G Iezzi","year":"2009","unstructured":"Iezzi, G. et al. CD40-CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells. Proc Natl Acad Sci USA 106, 876\u2013881 (2009).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep20401_CR51","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/j.1749-6632.1996.tb52660.x","volume":"795","author":"BL Kelsall","year":"1996","unstructured":"Kelsall, B. L., Stuber, E., Neurath, M. & Strober, W. Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses. Annals of the New York Academy of Sciences. 795, 116\u2013126 (1996).","journal-title":"Annals of the New York Academy of Sciences."},{"key":"BFsrep20401_CR52","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1111\/j.1365-2222.2008.03116.x","volume":"38","author":"M Okano","year":"2008","unstructured":"Okano, M. et al. Allergen-specific immunotherapy alters the expression of B and T lymphocyte attenuator, a co-inhibitory molecule, in allergic rhinitis. Clin Exp Allergy. 38, 1891\u20131900 (2008).","journal-title":"Clin Exp Allergy."},{"key":"BFsrep20401_CR53","doi-asserted-by":"crossref","unstructured":"Criteria for diagnosis of Behcet\u2019s disease. International Study Group for Behcet\u2019s Disease. Lancet. 335, 1078\u20131080 (1990).","DOI":"10.1016\/0140-6736(90)92643-V"},{"key":"BFsrep20401_CR54","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","volume":"131","author":"RW Read","year":"2001","unstructured":"Read, R. W. et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. American journal of ophthalmology. 131, 647\u2013652 (2001).","journal-title":"American journal of ophthalmology."},{"key":"BFsrep20401_CR55","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1089\/jir.2014.0042","volume":"35","author":"Z Ye","year":"2015","unstructured":"Ye, Z. et al. Decreased interleukin-37 expression in Vogt-Koyanagi-Harada disease and upregulation following immunosuppressive treatment. Journal of interferon & cytokine research: the official journal of the International Society for Interferon and Cytokine Research. 35, 265\u2013272 (2015).","journal-title":"Journal of interferon & cytokine research: the official journal of the International Society for Interferon and Cytokine Research"},{"key":"BFsrep20401_CR56","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25, 402\u2013408 (2001).","journal-title":"Methods."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep20401.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep20401","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep20401.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T03:02:05Z","timestamp":1672887725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep20401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,4]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,4,22]]}},"alternative-id":["BFsrep20401"],"URL":"https:\/\/doi.org\/10.1038\/srep20401","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,4]]},"assertion":[{"value":"11 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20401"}}